Research Advance about Poor Response to Anti-VEGF in Neovascular Age-Related Macular Degeneration
Abstract
Neovascular age-related macular degeneration (nAMD) has become one of the main causes of vision damage in middle-aged and elderly people, Now, anti-vascular endothelial growth factors (anti-VEGF) therapy has achieved a milestone in the treatment of nAMD, However, in clinical practice, the phenomenon of poor or even non-response of anti-VEGF drugs is still found, even maximal anti-VEGF treatment to some patients. The research on poor response to anti-VEGF therapy is also a hot topic in recent years. This article gives a brief review on diagnostic factors, This article gives a brief review on diagnostic factors, pathogenesis, characteristics of lesions and drug factors for the poor response of anti-VEGF drugs to nAMD.
References
[2] De Jong PT. Age-related macular degeneration[J]. N Engl J Med, 2006, 355(14): 1474-1485.
Copyright (c) 2023 Siyuan Nie
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear
Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.
